Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)00860-8
Affiliations:
28
Authors:
34
Go to article
Institutions Authors Share
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, China
6.000000
 0.18
CARsgen Therapeutics Ltd., China
5.000000
 0.15
Drum Tower Hospital, China
1.000000
 0.03
Ruijin Hospital, SJTU, China
1.000000
 0.03
Fujian Medical University Union Hospital, China
1.000000
 0.03
Peking University Shenzhen Hospital, China
1.000000
 0.03
Harbin Medical University Cancer Hospital, China
1.000000
 0.03
Zhongshan Hospital, Fudan University, China
1.000000
 0.03
The Second Affiliated Hospital to Nanchang University, China
1.000000
 0.03
The First Hospital of Jilin University, China
1.000000
 0.03
The Affiliated Hospital of Qingdao University, China
1.000000
 0.03
Henan Cancer Hospital, ZZU, China
1.000000
 0.03
Fudan University Shanghai Cancer Center (FUSCC), China
1.000000
 0.03
The First Affiliated Hospital, Zhejiang University School of Medicine, China
1.000000
 0.03
Anhui Provincial Cancer Hospital, China
1.000000
 0.03
Tongji Hospital (TJH), HUST, China
1.000000
 0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
1.000000
 0.03
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China
1.000000
 0.03
Northern Jiangsu People's Hospital, China
1.000000
 0.03
First Affiliated Hospital, ZZU, China
1.000000
 0.03
The First Affiliated Hospital of Xiamen University, China
1.000000
 0.03
Shandong Cancer Hospital, China
1.000000
 0.03
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
1.000000
 0.03
The First Hospital of China Medical University, China
1.000000
 0.03
Sichuan Cancer Hospital, China
0.500000
 0.01
University of Electronic Science and Technology of China (UESTC), China
0.500000
 0.01
Interested in Oncology and Carcinogenesis?